# PROGRAF
> **NDA210115** · New Drug Application · Sponsor: ASTELLAS · Approved 2018-05-24
## Drug
- **FDA Application Number:** NDA210115
- **Application type:** New Drug Application
- **Brand name:** PROGRAF
- **Generic name:** TACROLIMUS
- **Active ingredients:** TACROLIMUS
- **Dosage form:** FOR SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ASTELLAS
- **Manufacturer:** Astellas Pharma US, Inc.
- **First approval:** 2018-05-24
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210115)
---
*AI Analytics · CC0 1.0*